| 序号 |
CAS |
半岛bd体育手机客户端 名称 |
规格 |
包装 |
参考价格 |
| 1 |
280744-09-4 |
SB216763 |
≥98% |
|
询价 |
| 2 |
252917-06-9 |
CHIR99021(CT 99021) |
≥98% |
|
询价 |
| 3 |
326914-06-1 |
MHY1485 |
≥98% |
|
询价 |
| 4 |
221877-54-9 |
Zotarolimus(ABT578 A-179578) |
≥98% |
|
询价 |
| 5 |
1251156-08-7 |
XL388 |
≥98% |
|
询价 |
| 6 |
1207360-89-1 |
GDC-0349(RG7603) |
≥98% |
|
询价 |
| 7 |
1062159-35-6 |
WAY-600 |
≥98% |
|
询价 |
| 8 |
1062161-90-3 |
WYE-687 |
≥98% |
|
询价 |
| 9 |
1254036-66-2 |
GSK2292767 |
≥98% |
|
询价 |
| 10 |
1386874-06-1 |
Samotolisib(LY3023414 GTPL8918) |
≥98% |
|
询价 |
| 11 |
1620576-64-8 |
AZD8835 |
≥98% |
|
询价 |
| 12 |
522-17-8 |
Deguelin |
≥98% |
|
询价 |
| 13 |
1429639-50-8 |
CZ415 |
≥98% |
|
询价 |
| 14 |
1382979-44-3 |
GDC-0084(Paxalisib RG7666) |
≥98% |
|
询价 |
| 15 |
1092788-83-4 |
PP121 |
≥98% |
|
询价 |
| 16 |
914913-88-5 |
Palomid 529(P-529,SG00-529) |
≥98% |
|
询价 |
| 17 |
1144068-46-1 |
WYE125132(WYE132) |
≥98% |
|
询价 |
| 18 |
1009298-59-2 |
Vistusertib(AZD2014) |
≥98% |
|
询价 |
| 19 |
1062169-56-5 |
WYE-354 |
≥98% |
|
询价 |
| 20 |
936890-98-1 |
OSI-027(ASP-4786,CERC-006,AEVI-006) |
≥98% |
|
询价 |
| 21 |
1222998-36-8 |
Torin 1 |
≥98% |
|
询价 |
| 22 |
1224844-38-5 |
Sapanisertib(NK128 MLN0128 TAK228) |
≥98% |
|
询价 |
| 23 |
572924-54-0 |
Ridaforolimus(Deforolimus,MK8669,AP23573) |
≥98% |
|
询价 |
| 24 |
104987-11-3 |
Tacrolimus(FK-506,Fujimycin,FR900506,Prograf) |
≥98% |
|
询价 |
| 25 |
938440-64-3 |
KU-0063794 |
≥98% |
|
询价 |
| 26 |
162635-04-3 |
Temsirolimus(CCI779,NSC683864) |
≥98% |
|
询价 |
| 27 |
1009298-09-2 |
AZD8055 |
≥98% |
|
询价 |
| 28 |
1092351-67-1 |
Torkinib(PP242) |
≥98% |
|
询价 |
| 29 |
159351-69-6 |
Everolimus(RAD-001,SDZ-RAD) |
≥98% |
|
询价 |
| 30 |
53123-88-9 |
Rapamycin(Sirolimus AY22989) |
≥98% |
|
询价 |
| 31 |
612847-09-3 |
Akti-1/2(AKT inhibitor VIII) |
≥98% |
|
询价 |
| 32 |
1616632-77-9 |
TIC10(imipridone,ONC201,NSC350625) |
≥98% |
|
询价 |
| 33 |
305834-79-1 |
SC79 |
≥98% |
|
询价 |
| 34 |
1056901-62-2 |
AT13148 |
≥98% |
|
询价 |
| 35 |
1047644-62-1 |
Afuresertib(GSK-2110183) |
≥98% |
|
询价 |
| 36 |
41276-02-2 |
TIC10 Analogue |
≥98% |
|
询价 |
| 37 |
58066-85-6 |
Miltefosine |
≥98% |
|
询价 |
| 38 |
1191951-57-1 |
PHT-427(CS-0223) |
≥98% |
|
询价 |
| 39 |
2414909-94-5 |
RETV804M kinase inhibitor |
≥98% |
|
询价 |
| 40 |
1675204-51-9 |
BMS-242 |
≥98% |
|
询价 |
| 41 |
1268524-71-5 |
(-)-JQ-1 |
≥98% |
|
询价 |
| 42 |
1818314-88-3 |
BMS-1166 |
≥98% |
|
询价 |
| 43 |
2421117-98-6 |
BC-DXI-843 |
≥98% |
|
询价 |
| 44 |
146479-72-3 |
Follicle-stimulating hormone |
≥98% |
|
询价 |
| 45 |
1353563-85-5 |
AUNP-12 |
≥98% |
|
询价 |
| 46 |
5608-24-2 |
PRIMA-1 |
≥98% |
|
询价 |
| 47 |
1235034-55-5 |
A-1155463 |
≥98% |
|
询价 |
| 48 |
1430844-80-6 |
A-1331852 |
≥98% |
|
询价 |
| 49 |
1821496-27-8 |
BDA-366 |
≥98% |
|
询价 |
| 50 |
1313363-54-0 |
NVP-CGM097 |
≥98% |
|
询价 |
| 51 |
1629654-95-0 |
PD-1/PD-L1 Inhibitor 3 |
≥98% |
|
询价 |
| 52 |
2244678-29-1 |
TH257 |
≥98% |
|
询价 |
| 53 |
2752453-58-8 |
Metallo-β-lactamase-IN-7 |
≥98% |
|
询价 |
| 54 |
1439899-44-1 |
Metallo-β-lactamase-IN-6 |
≥98% |
|
询价 |
| 55 |
94035-02-6 |
Hydroxypropyl-beta-cyclodextrin |
≥98% |
|
询价 |
| 56 |
63675-72-9 |
Nisoldipine |
≥98% |
|
询价 |
| 57 |
608141-41-9 |
Apremilast |
≥98% |
|
询价 |
| 58 |
1234015-57-6 |
Prexasertib mesylate hydrate(LY 2606368) |
≥98% |
|
询价 |
| 59 |
1234015-54-3 |
Prexasertib 2HCl(LY-2606368) |
≥98% |
|
询价 |
| 60 |
1234015-55-4 |
Prexasertib mesylate(LY-2606368 mesylate) |
≥98% |
|
询价 |
m.cnreagent.com
